Sartorius Stedim Biotech regains 0.9% this Wednesday, to 198.50 euros, while JP Morgan remains ‘overweight’ on the file with a target price which rises from 230 to 280 euros. Morgan Stanley had previously cut its target from 265 to 220 euros with an ‘online weighting’ opinion, while the group…
©2023 Boursier.com